Xi'an, China

Qiao Zeng

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Shaanxi University of Science and Technology, Xi'an Kangyuansheng Biomedical Technology Co., Ltd., Xi'an Taikomed Pharmaceutical Technology Co., Ltd.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiao Zeng. Retrieved from https://idiyas.com/inventor/qiao-zeng-ng9o6ecb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 42.9

Average Co-Inventor Count = 13.2

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Qiao Zeng - Revolutionizing Technology in Xi'an

Introduction: Qiao Zeng is a pioneering inventor based in Xi'an, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Qiao Zeng holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Qiao Zeng has worked with leading tech companies and research institutions, consistently pushing the boundaries of technological advancements.

Collaborations: Throughout her career, Qiao Zeng has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge sharing in the tech industry.

Conclusion: Qiao Zeng's relentless pursuit of innovation and her passion for creating technology that shapes the future make her a true trailblazer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…